Premier Alternatives

Kiffik Biomedical

Providence, RI · Founded 2018 · Privately Held (backing)

Developer of an interstitial fluid technology designed to expand the understanding of diseases. Kiffik Biomedical is based in Providence, RI and was founded in 2018. It was valued at $185 million at its early-stage round in Oct 2023, the last priced event on record. It has raised $51.3 million across 1 recorded round; the latest was an $830,000 seed round in Sep 2021.

PMV mark · valuation
$185.0M
Oct 2026
Priced at
its early-stage round
Oct 2023
Total raised
$51.3M
Last round
Seed Round
Sep 2021

Kiffik Biomedical key facts

as of Oct 2026
  • Developer of an interstitial fluid technology designed to expand the understanding of diseases.
  • Kiffik Biomedical is valued at approximately $185.0M as of Oct 2026, set at its early-stage round, Oct 2023; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $51.3M across 1 recorded rounds; the latest was Seed Round ($830K) in Sep 2021.
  • Notable investors include Global Emerging Markets, West Midlands Health Tech Innovation Accelerator.
  • Kiffik Biomedical has filed 2 Form Ds with the SEC, most recently Jun 2022 ($830K sold to 12 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$185.0M

Valued at $185.0M at its early-stage round, Oct 2023. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Kiffik Biomedical with a free account
  • ·Watch Kiffik Biomedical: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Kiffik Biomedical funding rounds

1 rounds
Sep 2021Seed Round$830KSEC filing▮
Full funding history →

Kiffik Biomedical valuation

Kiffik Biomedical was valued at $185 million at its early-stage round in Oct 2023. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Kiffik Biomedical raised?

Kiffik Biomedical has raised $51.3 million in total; 1 of its rounds is on record. The largest on record was an $830,000 seed round in Sep 2021.

Kiffik Biomedical has filed 2 Form Ds with the SEC, most recently in Jun 2022 ($830,000 sold to 12 investors).

Kiffik Biomedical investors

2 investors are on record for Kiffik Biomedical, including Global Emerging Markets and West Midlands Health Tech Innovation Accelerator. The seed round in Sep 2021 drew 12 investors.

About Kiffik Biomedical

Developer of an interstitial fluid technology designed to expand the understanding of diseases. The company's technology can be applied as a sampling and monitoring tool for drug research in preclinical and clinical trials as an alternative medium for bio-derivative production, enabling medical researchers and biopharmaceutical companies to find new possibilities in preventive medicine and empower patients to manage their health proactively.

Sector
Healthcare
HQ
Providence, RI, United States
Founded
2018
Employees
21
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.